1. Petersen PE. Strengthening the prevention of oral cancer:
the WHO perspective. Community Dent Oral Epidemiol.
2005;33(6):397-9. doi: 10.1111/j.1600-0528.2005.00251.x.
2. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E,
Rubenstein EB. The burdens of cancer therapy. Clinical and
economic outcomes of chemotherapy-induced mucositis.
Cancer. 2003;98(7):1531-9. doi: 10.1002/cncr.11671.
3. Pulito C, Cristaudo A, Porta C, Zapperi S, Blandino G,
Morrone A, et al. Oral mucositis: the hidden side of cancer
therapy. J Exp Clin Cancer Res. 2020;39(1):210. doi: 10.1186/
s13046-020-01715-7.
4. Wang Y, Zeng X, Yang X, Que J, Du Q, Zhang Q, et al. Oral
health, caries risk profiles, and oral microbiome of pediatric
patients with leukemia submitted to chemotherapy. Biomed
Res Int. 2021;2021:6637503. doi: 10.1155/2021/6637503.
5. Daugėlaitė G, Užkuraitytė K, Jagelavičienė E, Filipauskas A.
Prevention and treatment of chemotherapy and radiotherapy
induced oral mucositis. Medicina (Kaunas). 2019;55(2):25.
doi: 10.3390/medicina55020025.
6. Stokman MA, Spijkervet FK, Boezen HM, Schouten JP,
Roodenburg JL, de Vries EG. Preventive intervention
possibilities in radiotherapy- and chemotherapy-induced
oral mucositis: results of meta-analyses. J Dent Res.
2006;85(8):690-700. doi: 10.1177/154405910608500802.
7. Hong CH, Gueiros LA, Fulton JS, Cheng KK, Kandwal A,
Galiti D, et al. Systematic review of basic oral care for the
management of oral mucositis in cancer patients and clinical
practice guidelines. Support Care Cancer. 2019;27(10):3949-
67. doi: 10.1007/s00520-019-04848-4.
8. Henke M, Alfonsi M, Foa P, Giralt J, Bardet E, Cerezo L, et
al. Palifermin decreases severe oral mucositis of patients
undergoing postoperative radiochemotherapy for head
and neck cancer: a randomized, placebo-controlled
trial. J Clin Oncol. 2011;29(20):2815-20. doi: 10.1200/
jco.2010.32.4103.
9. Xu JL, Xia R, Sun ZH, Sun L, Min X, Liu C, et al. Effects of
honey use on the management of radio/chemotherapyinduced
mucositis: a meta-analysis of randomized controlled
trials. Int J Oral Maxillofac Surg. 2016;45(12):1618-25. doi:
10.1016/j.ijom.2016.04.023.
10. Giro C, Berger B, Bölke E, Ciernik IF, Duprez F, Locati L, et
al. High rate of severe radiation dermatitis during radiation
therapy with concurrent cetuximab in head and neck cancer:
results of a survey in EORTC institutes. Radiother Oncol.
2009;90(2):166-71. doi: 10.1016/j.radonc.2008.09.007.
11. Wischmeyer PE. Clinical applications of L-glutamine: past,
present, and future. Nutr Clin Pract. 2003;18(5):377-85. doi:
10.1177/0115426503018005377.
12. Neu J, DeMarco V, Li N. Glutamine: clinical applications
and mechanisms of action. Curr Opin Clin Nutr Metab
Care. 2002;5(1):69-75. doi: 10.1097/00075197-200201000-
00013.
13. Skubitz KM, Anderson PM. Oral glutamine to prevent
chemotherapy induced stomatitis: a pilot study. J Lab Clin Med.
1996;127(2):223-8. doi: 10.1016/s0022-2143(96)90082-7.
14. Silverman S Jr. Diagnosis and management of oral mucositis.
J Support Oncol. 2007;5(2 Suppl 1):13-21.
15. Savarese DM, Savy G, Vahdat L, Wischmeyer PE, Corey
B. Prevention of chemotherapy and radiation toxicity with
glutamine. Cancer Treat Rev. 2003;29(6):501-13. doi:
10.1016/s0305-7372(03)00133-6.
16. Choi K, Lee SS, Oh SJ, Lim SY, Lim SY, Jeon WK, et al. The
effect of oral glutamine on 5-fluorouracil/leucovorin-induced
mucositis/stomatitis assessed by intestinal permeability
test. Clin Nutr. 2007;26(1):57-62. doi: 10.1016/j.
clnu.2006.07.003.
17. Mead GM. Management of oral mucositis associated with
cancer chemotherapy. Lancet. 2002;359(9309):815-6. doi:
10.1016/s0140-6736(02)07960-6.
18. Leung HW, Chan AL. Glutamine in alleviation of radiationinduced
severe oral mucositis: a meta-analysis. Nutr Cancer.
2016;68(5):734-42. doi: 10.1080/01635581.2016.1159700.
19. Jebb SA, Osborne RJ, Maughan TS, Mohideen N, Mack
P, Mort D, et al. 5-fluorouracil and folinic acid-induced
mucositis: no effect of oral glutamine supplementation. Br J
Cancer. 1994;70(4):732-5. doi: 10.1038/bjc.1994.385.
20. Anderson PM, Schroeder G, Skubitz KM. Oral glutamine
reduces the duration and severity of stomatitis after
cytotoxic cancer chemotherapy. Cancer. 1998;83(7):1433-
9. doi: 10.1002/(sici)1097-0142(19981001)83:7<1433::aidcncr22>3.0.co;2-4.
21. Okuno SH, Woodhouse CO, Loprinzi CL, Sloan JA, LaVasseur
BI, Clemens-Schutjer D, et al. Phase III controlled evaluation
of glutamine for decreasing stomatitis in patients receiving
fluorouracil (5-FU)-based chemotherapy. Am J Clin Oncol.
1999;22(3):258-61. doi: 10.1097/00000421-199906000-
00009.
22. Ward E, Smith M, Henderson M, Reid U, Lewis I, Kinsey S, et
al. The effect of high-dose enteral glutamine on the incidence
and severity of mucositis in paediatric oncology patients. Eur J
Clin Nutr. 2009;63(1):134-40. doi: 10.1038/sj.ejcn.1602894.
23. Choi K, Lee SS, Oh SJ, Lim SY, Lim SY, Jeon WK, et al. The
effect of oral glutamine on 5-fluorouracil/leucovorin-induced
mucositis/stomatitis assessed by intestinal permeability
test. Clin Nutr. 2007;26(1):57-62. doi: 10.1016/j.
clnu.2006.07.003.
24. Rubio IT, Cao Y, Hutchins LF, Westbrook KC, Klimberg VS.
Effect of glutamine on methotrexate efficacy and toxicity.
Ann Surg. 1998;227(5):772-8. doi: 10.1097/00000658-
199805000-00018.
25. Cockerham MB, Weinberger BB, Lerchie SB. Oral glutamine
for the prevention of oral mucositis associated with highdose paclitaxel
and melphalan for autologous bone marrow
transplantation. Ann Pharmacother. 2000;34(3):300-3. doi:
10.1345/aph.19168.
26. Peterson DE, Jones JB, Petit RG 2nd. Randomized, placebocontrolled
trial of Saforis for prevention and treatment of oral
mucositis in breast cancer patients receiving anthracyclinebased chemotherapy.
Cancer. 2007;109(2):322-31. doi:
10.1002/cncr.22384.
27. Lopez-Vaquero D, Gutierrez-Bayard L, Rodriguez-Ruiz
JA, Saldaña-Valderas M, Infante-Cossio P. Double-blind
randomized study of oral glutamine on the management of
radio/chemotherapy-induced mucositis and dermatitis in
head and neck cancer. Mol Clin Oncol. 2017;6(6):931-6. doi:
10.3892/mco.2017.1238.
28. Klimberg VS, Salloum RM, Kasper M, Plumley DA, Dolson
DJ, Hautamaki RD, et al. Oral glutamine accelerates healing
of the small intestine and improves outcome after whole
abdominal radiation. Arch Surg. 1990;125(8):1040-5. doi:
10.1001/archsurg.1990.01410200104017.
29. Ziegler TR, Bye RL, Persinger RL, Young LS, Antin JH, Wilmore
DW. Glutamine-enriched parenteral nutrition increases
circulating lymphocytes after bone marrow transplantation.
JPEN J Parenter Enteral Nutr. 1994;18(Suppl 1):17S.
30. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K,
Bye R, et al. Clinical and metabolic efficacy of glutaminesupplemented
parenteral nutrition after bone marrow
transplantation. A randomized, double-blind, controlled
study. Ann Intern Med. 1992;116(10):821-8. doi:
10.7326/0003-4819-116-10-821.
31. Schloerb PR, Amare M. Total parenteral nutrition with
glutamine in bone marrow transplantation and other
clinical applications (a randomized, double-blind study).
JPEN J Parenter Enteral Nutr. 1993;17(5):407-13. doi:
10.1177/0148607193017005407.
32. Lacey JM, Wilmore DW. Is glutamine a conditionally essential
amino acid? Nutr Rev. 1990;48(8):297-309. doi: 10.1111/
j.1753-4887.1990.tb02967.x.
33. Souba WW, Klimberg VS, Plumley DA, Salloum RM, Flynn
TC, Bland KI, et al. The role of glutamine in maintaining
a healthy gut and supporting the metabolic response to
injury and infection. J Surg Res. 1990;48(4):383-91. doi:
10.1016/0022-4804(90)90080-l.
34. Parry-Billings M, Evans J, Calder PC, Newsholme EA. Does
glutamine contribute to immunosuppression after major
burns? Lancet. 1990;336(8714):523-5. doi: 10.1016/0140-
6736(90)92083-t.
35. Roth E, Funovics J, Mühlbacher F, Schemper M, Mauritz
W, Sporn P, et al. Metabolic disorders in severe abdominal
sepsis: glutamine deficiency in skeletal muscle. Clin Nutr.
1982;1(1):25-41. doi: 10.1016/0261-5614(82)90004-8.
36. Aquino VM, Harvey AR, Garvin JH, Godder KT, Nieder
ML, Adams RH, et al. A double-blind randomized placebocontrolled
study of oral glutamine in the prevention of
mucositis in children undergoing hematopoietic stem cell
transplantation: a pediatric blood and marrow transplant
consortium study. Bone Marrow Transplant. 2005;36(7):611-
6. doi: 10.1038/sj.bmt.1705084.
37. Leitão RF, Ribeiro RA, Lira AM, Silva LR, Bellaguarda EA,
Macedo FD, et al. Glutamine and alanyl-glutamine accelerate
the recovery from 5-fluorouracil-induced experimental
oral mucositis in hamster. Cancer Chemother Pharmacol.
2008;61(2):215-22. doi: 10.1007/s00280-007-0463-2.
38. Cerchietti LC, Navigante AH, Lutteral MA, Castro MA,
Kirchuk R, Bonomi M, et al. Double-blinded, placebocontrolled trial
on intravenous L-alanyl-L-glutamine in the
incidence of oral mucositis following chemoradiotherapy in
patients with head-and-neck cancer. Int J Radiat Oncol Biol
Phys. 2006;65(5):1330-7. doi: 10.1016/j.ijrobp.2006.03.042.
39. Daniele B, Perrone F, Gallo C, Pignata S, De Martino S, De
Vivo R, et al. Oral glutamine in the prevention of fluorouracil
induced intestinal toxicity: a double blind, placebo
controlled, randomised trial. Gut. 2001;48(1):28-33. doi:
10.1136/gut.48.1.28.
40. Tsujimoto T, Yamamoto Y, Wasa M, Takenaka Y, Nakahara S,
Takagi T, et al. L-glutamine decreases the severity of mucositis
induced by chemoradiotherapy in patients with locally
advanced head and neck cancer: a double-blind, randomized,
placebo-controlled trial. Oncol Rep. 2015;33(1):33-9. doi:
10.3892/or.2014.3564.
41. Bellon G, Monboisse JC, Randoux A, Borel JP. Effects
of preformed proline and proline amino acid precursors
(including glutamine) on collagen synthesis in human
fibroblast cultures. Biochim Biophys Acta. 1987;930(1):39-
47. doi: 10.1016/0167-4889(87)90153-4.
42. Blijlevens NM, Donnelly JP, Naber AH, Schattenberg AV,
DePauw BE. A randomised, double-blinded, placebocontrolled,
pilot study of parenteral glutamine for allogeneic
stem cell transplant patients. Support Care Cancer.
2005;13(10):790-6. doi: 10.1007/s00520-005-0790-y
)